Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 7838638 Anti-IL-17 antibodies

Patent 7838638 was granted and assigned to Eli Lilly and Company on November, 2010 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Jonathan Wendell Tetreault0

Ling Liu0

Barrett Allan0

Chi-Kin Chow0

Jirong Lu0

Date of Patent

November 23, 2010

0

Patent Application Number

120953980

Date Filed

December 5, 2006

0

Patent Citations Received

US Patent 12060425 High affinity antibodies to PD-1 and LAG-3 and bispecific binding proteins made therefrom

0

Patent Primary Examiner

Stephen L. Rawlings

0

Patent abstract

Anti-IL-17 antibodies are identified that are characterized as having a high affinity and slow off rate for human IL-17. The antibodies of the invention may be chimeric, humanized or fully human antibodies, immunoconjugates of the antibodies or antigen-binding fragments thereof. The antibodies of the invention are useful in particular for treating autoimmune, inflammatory, cell proliferative and developmental disorders.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7838638 Anti-IL-17 antibodies

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.